Financhill
Sell
36

CNSP Quote, Financials, Valuation and Earnings

Last price:
$0.11
Seasonality move :
-46.41%
Day range:
$0.10 - $0.12
52-week range:
$0.10 - $70.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.90x
Volume:
4.6M
Avg. volume:
7.3M
1-year change:
-99.78%
Market cap:
$6.4M
Revenue:
--
EPS (TTM):
-$70.72

Earnings Data

Next earnings date for CNSP
Apr 01
2025
Most recent earnings per share
-$0.25
Missed by $0.25
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -- --
11/14/2024 Q3 -- -- -$0.25 -- --
08/14/2024 Q2 -- -- -$6.72 -- --
05/15/2024 Q1 -- -- -$20.50 -- --
12/31/2023 Q4 -- -- -$43.25 -- --
11/15/2023 Q3 -- -- -$54.14 -- --
06/30/2023 Q2 -- -- -$51.86 -- --
03/31/2023 Q1 -- -- -$129.50 -- --
12/31/2022 Q4 -- -- -$177.50 -- --
11/11/2022 Q3 -- -- -$128.00 -- --
08/12/2022 Q2 -- -- -$133.50 -- --
05/13/2022 Q1 -- -- -$122.00 -- --
03/03/2022 Q4 -- -- -$180.00 -- --
11/12/2021 Q3 -- -- -$210.00 -- --
08/13/2021 Q2 -- -- -$225.00 -- --
05/14/2021 Q1 -- -- -$225.00 -- --
03/12/2021 Q4 -- -- -$270.00 -- --
11/12/2020 Q3 -- -- -$180.00 -- --
08/13/2020 Q2 -- -- -$225.00 -- --
05/15/2020 Q1 -- -- -$180.00 -- --
03/12/2020 Q4 -- -- -$255.00 -- --
09/30/2019 Q3 -- -- -$75.00 -- --
06/30/2019 Q2 -- -- -$45.00 -- --
03/31/2019 Q1 -- -- -$23.37 -- --
12/31/2018 Q4 -- -- -$732.84 -- --
09/30/2018 Q3 -- -- -$21.35 -- --
06/30/2018 Q2 -- -- -$24.58 -- --

CNS Pharmaceuticals Earnings Questions

  • How Much did CNS Pharmaceuticals Generate in Revenue Last Quarter?

    CNS Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did CNS Pharmaceuticals Beat Earnings Last Quarter?

    CNS Pharmaceuticals announced earnings per share of -$0.25 which represents a miss of analyst forecast a -- per share.

  • Is CNS Pharmaceuticals Profitable?

    CNS Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CNS Pharmaceuticals EPS Next Year?

    CNS Pharmaceuticals's earnings are forecast to grow from -$500.00 per share to -- per share next year representing an increase of --.

  • When is CNS Pharmaceuticals's Earnings Date?

    CNS Pharmaceuticals's next earnings date is April 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock